| 17beta-estradiol | increases expression | ISO | RGD:1345133 | 6480464 | Estradiol results in increased expression of HLA-F mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | increases expression | ISO | RGD:1347423 | 6480464 | Estradiol results in increased expression of HLA-G mRNA | CTD | PMID:19619570 PMID:21185374 |
| 17beta-estradiol | increases expression | ISO | RGD:1345133 | 6480464 | Estradiol results in increased expression of HLA-F mRNA | CTD | PMID:19619570 PMID:21185374 |
| 17beta-estradiol | increases expression | ISO | RGD:1347423 | 6480464 | Estradiol results in increased expression of HLA-G mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1347423 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of HLA-G mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1345133 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HLA-F mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1345133 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HLA-F mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1347423 | 6480464 | Tetrachlorodibenzodioxin affects the expression of HLA-G mRNA | CTD | PMID:22574217 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:11205 | 6480464 | Tetrachlorodibenzodioxin affects the expression of H2-M3 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1347423 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of HLA-G mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1347423 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HLA-G mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1345133 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HLA-F mRNA | CTD | PMID:19619570 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of RT1-M3-1 mRNA | CTD | PMID:21346803 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1347423 | 6480464 | [decitabine affects the methylation of HLA-G promoter] which affects the expression of HLA-G protein | CTD | PMID:18823661 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1347423 | 6480464 | [decitabine affects the methylation of HLA-G promoter] which affects the expression of HLA-G protein | CTD | PMID:18823661 PMID:18823661 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1347423 | 6480464 | [decitabine affects the methylation of HLA-G promoter] which affects the expression of HLA-G mRNA | CTD | PMID:18498645 more ... |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1347423 | 6480464 | [decitabine affects the methylation of HLA-G promoter] which affects the expression of HLA-G mRNA | CTD | PMID:18498645 PMID:18823661 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:1347423 | 6480464 | decitabine results in increased expression of HLA-G mRNA; more ... | CTD | PMID:17949227 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1347423 | 6480464 | [decitabine affects the methylation of HLA-G promoter] which affects the expression of HLA-G mRNA | CTD | PMID:18823661 PMID:18498645 |
| 5-fluorouracil | increases expression | ISO | RGD:1345133 | 6480464 | Fluorouracil results in increased expression of HLA-F mRNA | CTD | PMID:16101138 |
| 5-fluorouracil | increases expression | ISO | RGD:1347423 | 6480464 | Fluorouracil results in increased expression of HLA-G mRNA | CTD | PMID:16101138 |
| acetylsalicylic acid | decreases expression | ISO | RGD:1347423 | 6480464 | Aspirin results in decreased expression of HLA-G mRNA | CTD | PMID:14976132 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1345133 | 6480464 | Tretinoin results in increased expression of HLA-F mRNA | CTD | PMID:16054129 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1347423 | 6480464 | Tretinoin results in increased expression of HLA-G mRNA | CTD | PMID:15498508 PMID:15894607 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1347423 | 6480464 | Tretinoin results in increased expression of HLA-G mRNA | CTD | PMID:15498508 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of RT1-M3-1 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:11205 | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of H2-M3 mRNA] | CTD | PMID:22228805 |
| benzo[a]pyrene | increases expression | ISO | RGD:11205 | 6480464 | Benzo(a)pyrene results in increased expression of H2-M3 mRNA | CTD | PMID:22228805 |
| cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of RT1-M3-1 promoter | CTD | PMID:22457795 |
| choline | multiple interactions | ISO | RGD:11205 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of H2-M3 mRNA | CTD | PMID:20938992 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:11205 | 6480464 | Ciguatoxins affects the expression of H2-M3 mRNA | CTD | PMID:18353800 |
| cisplatin | multiple interactions | ISO | RGD:1347423 | 6480464 | [Piroxicam co-treated with Cisplatin] results in increased expression of HLA-G mRNA | CTD | PMID:21858171 |
| cisplatin | affects response to substance | ISO | RGD:1347423 | 6480464 | HLA-G protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 |
| cobalt dichloride | increases expression | ISO | RGD:1347423 | 6480464 | cobaltous chloride results in increased expression of HLA-G mRNA | CTD | PMID:19376846 |
| cyclosporin A | increases expression | ISO | RGD:1347423 | 6480464 | Cyclosporine results in increased expression of HLA-G mRNA | CTD | PMID:22147139 |
| dexamethasone | increases expression | ISO | RGD:11205 | 6480464 | Dexamethasone results in increased expression of H2-M3 mRNA | CTD | PMID:21041162 |
| diarsenic trioxide | decreases expression | ISO | RGD:1345133 | 6480464 | arsenic trioxide results in decreased expression of HLA-F mRNA | CTD | PMID:19128835 PMID:15725085 |
| diarsenic trioxide | decreases expression | ISO | RGD:1347423 | 6480464 | arsenic trioxide results in decreased expression of HLA-G mRNA | CTD | PMID:15725085 more ... |
| diarsenic trioxide | decreases expression | ISO | RGD:1347423 | 6480464 | arsenic trioxide results in decreased expression of HLA-G mRNA | CTD | PMID:15761015 more ... |
| diarsenic trioxide | decreases expression | ISO | RGD:1347423 | 6480464 | arsenic trioxide results in decreased expression of HLA-G mRNA | CTD | PMID:19128835 more ... |
| diarsenic trioxide | decreases expression | ISO | RGD:1345133 | 6480464 | arsenic trioxide results in decreased expression of HLA-F mRNA | CTD | PMID:15725085 PMID:19128835 |
| disodium selenite | increases expression | ISO | RGD:1347423 | 6480464 | Sodium Selenite results in increased expression of HLA-G mRNA | CTD | PMID:18175754 |
| elemental selenium | decreases expression | ISO | RGD:1345133 | 6480464 | Selenium results in decreased expression of HLA-F mRNA | CTD | PMID:19244175 |
| elemental selenium | increases expression | ISO | RGD:1347423 | 6480464 | Selenium results in increased expression of HLA-G mRNA | CTD | PMID:19244175 |
| elemental selenium | increases expression | ISO | RGD:1345133 | 6480464 | Selenium results in increased expression of HLA-F mRNA | CTD | PMID:19244175 |
| folic acid | multiple interactions | ISO | RGD:11205 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of H2-M3 mRNA | CTD | PMID:20938992 |
| indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of RT1-M3-1 mRNA | CTD | PMID:21396975 |
| isotretinoin | increases expression | ISO | RGD:1345133 | 6480464 | Isotretinoin results in increased expression of HLA-F mRNA | CTD | PMID:20436886 |
| isotretinoin | increases expression | ISO | RGD:1347423 | 6480464 | Isotretinoin results in increased expression of HLA-G mRNA | CTD | PMID:20436886 |
| L-methionine | multiple interactions | ISO | RGD:11205 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of H2-M3 mRNA | CTD | PMID:20938992 |
| methotrexate | decreases expression | ISO | RGD:1347423 | 6480464 | Methotrexate results in decreased expression of HLA-G mRNA | CTD | PMID:17400583 |
| mifepristone | multiple interactions | ISO | RGD:1347423 | 6480464 | Mifepristone inhibits the reaction [Progesterone results in increased expression of HLA-G mRNA]; more ... | CTD | PMID:16210391 |
| paracetamol | affects expression | ISO | RGD:11205 | 6480464 | Acetaminophen affects the expression of H2-M3 mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | ISO | RGD:1345133 | 6480464 | Acetaminophen results in decreased expression of HLA-F mRNA | CTD | PMID:22230336 |
| piroxicam | multiple interactions | ISO | RGD:1347423 | 6480464 | [Piroxicam co-treated with Cisplatin] results in increased expression of HLA-G mRNA | CTD | PMID:21858171 |
| progesterone | multiple interactions | ISO | RGD:1347423 | 6480464 | Mifepristone inhibits the reaction [Progesterone results in increased expression of HLA-G mRNA]; more ... | CTD | PMID:16210391 |
| progesterone | increases expression | ISO | RGD:1347423 | 6480464 | Progesterone results in increased expression of HLA-G protein; more ... | CTD | PMID:16210391 |
| resveratrol | increases expression | ISO | RGD:1345133 | 6480464 | resveratrol results in increased expression of HLA-F mRNA | CTD | PMID:17257620 |
| rosiglitazone | decreases expression | EXP | | 6480464 | rosiglitazone results in decreased expression of RT1-M3-1 mRNA | CTD | PMID:21515302 |
| selenium atom | decreases expression | ISO | RGD:1345133 | 6480464 | Selenium results in decreased expression of HLA-F mRNA | CTD | PMID:19244175 |
| selenium atom | increases expression | ISO | RGD:1347423 | 6480464 | Selenium results in increased expression of HLA-G mRNA | CTD | PMID:19244175 |
| selenium atom | increases expression | ISO | RGD:1345133 | 6480464 | Selenium results in increased expression of HLA-F mRNA | CTD | PMID:19244175 |
| tamibarotene | increases expression | ISO | RGD:1347423 | 6480464 | Am 80 results in increased expression of HLA-G mRNA; more ... | CTD | PMID:15498508 |
| trans-resveratrol | increases expression | ISO | RGD:1345133 | 6480464 | resveratrol results in increased expression of HLA-F mRNA | CTD | PMID:17257620 |
| valproic acid | affects expression | ISO | RGD:11205 | 6480464 | Valproic Acid affects the expression of H2-M3 mRNA | CTD | PMID:17963808 PMID:17292431 |
| valproic acid | increases expression | ISO | RGD:1347423 | 6480464 | Valproic Acid results in increased expression of HLA-G mRNA | CTD | PMID:19101580 |
| valproic acid | increases expression | ISO | RGD:1345133 | 6480464 | Valproic Acid results in increased expression of HLA-F mRNA | CTD | PMID:19101580 |
| valproic acid | affects expression | ISO | RGD:11205 | 6480464 | Valproic Acid affects the expression of H2-M3 mRNA | CTD | PMID:17292431 PMID:17963808 |
| zinc atom | increases expression | ISO | RGD:1347423 | 6480464 | Zinc deficiency results in increased expression of HLA-G mRNA | CTD | PMID:18356318 |
| zinc(0) | increases expression | ISO | RGD:1347423 | 6480464 | Zinc deficiency results in increased expression of HLA-G mRNA | CTD | PMID:18356318 |